A round of thanks is clearly owed to retail investors, who have been faithfully buying the dip as institutional investors and hedge funds shied away. Not everyone is enthusiastic, though.

However, activity is likely to slow as the year advances and the need to add to stocks of pharmaceuticals diminishes, while the higher U.S. tariffs on most other goods that have been imposed over ...

'She treats my sibling and me as virtual strangers' ...

The ECB's rate cuts have drawn the attention of President Trump, who has criticized the more cautious stance of Federal Reserve Chair Jerome Powell. U.S. futures were little changed after new data on ...

The American consumer giant also said it would trim its portfolio of brands. Jack Daniel's maker Brown-Forman expects organic sales to decline this fiscal year as consumer demand softens in the face ...